OLB The OLB rises 23 percent after Q4 2025 earnings outpace consensus analyst EPS estimates IRS Correspondence Audit Operational Updates Compliance Guidance and Systemic Reforms Enliven Therapeutics ELVN Stock Industry Opportunities 082 20260427